The diverse members of the Board combine their experiences and expertise to guide the Chief Executive, who works with the Senior Management Team to achieve the charity's vision.
Please read the Cystic Fibrosis Trust - Governance Manual.
Our current Trustees are:
George R Jenkins OBE - Chairman
George was elected as Chairman of the Cystic Fibrosis Trust in July 2012. He was Deputy Chairman and Chairman of Governance and Audit at NHS Blood and Transplant in the immediate past, an organisation with approximately £500 million turnover and 6,000 staff providing national support services to the NHS, of which the most publicly aware subsidiary is the National Blood Service. George is also Chairman of Port of Dover and Dover Harbour Board. Previously he was Chairman of South London Healthcare NHS Trust, Interim Chairman of Maidstone and Tunbridge Wells NHS Trust, responsible for stabilising that organisation and replacing board and governance structures after high profile failings in clinical services, and Chairman of East Kent Hospitals Trust. He was Chairman of the Medway Dock Labour Board, Executive Chairman and Managing Director of the Transit Group and has held a number of executive and non-executive positions in the ports industry. George was awarded the OBE for services to healthcare in the 2011 Queen's Birthday Honours.
Find out more about our Chairman.
Professor Andrew Jones
Prof Andrew Jones has been a Consultant Physician at the Manchester Adult Cystic Fibrosis Centre since 2002 and holds an Honorary Clinical Chair at the University of Manchester. He has published over 100 papers. Prof Jones chaired the UK Cystic Fibrosis Trust Infection Control Group that developed national guidelines for control of B. cepacia complex, P. aeruginosa, MRSA and M. abscessus. He is a member of the UK Cystic Fibrosis Trust Microbiology Standards Working Group, and was previously a member of the Cystic Fibrosis Trust Research Advisory Committee 2004-2013, then a member of the Cystic Fibrosis Trust Research Strategy Implementation Board 2013-2014.
Caroline Cartellieri Karlsen
Caroline has held senior executive roles in retail and media. She currently runs a consulting business focusing on digital commerce and online media. She was previously COO of MySpace International and prior to that UK Managing Director of Expedia. Before that she held different positions at Kingfisher plc, including Head of Strategy and Commercial Finance Director. Prior to this, while living in New York, she set up her own e-commerce business selling luxury gifts. She started out her career as a consultant for the Boston Consulting Group and McKinsey & Co. Caroline's older daughter, born in 2010, was diagnosed with cystic fibrosis at four weeks old. Since then Caroline has been actively raising funds for the Trust, including by taking part in a 100km nightly cycle ride through London and by hosting a couple of black tie galas. She joined as a Trustee in 2013.
Peter is a business and finance professional with an extensive track record of leading complex transactions (acquisitions and capital raisings on public markets) for UK and international corporations. He has a wealth of experience in advising senior executives and boards on the execution of their strategic goals and all finance related matters. Peter has been an active member of the Finance Committee of the Cystic Fibrosis Trust for two years before joining the Board of Trustees. Peter grew up in Canada with his cousin and close friend, Tim Skelton, who was born with cystic fibrosis. To honour his memory and for those people, with their families and friends, now living with cystic fibrosis, Peter wants to bring his experience and make his contribution towards beating cystic fibrosis.
Professor John Price MA, MB, BCh. MD, DCH, FRCP, FRCPCH
Professor John Price was educated at Dulwich College, and at St John’s College Cambridge. In 1978 he was appointed Consultant Paediatrician at King's College Hospital where he founded the Paediatric Respiratory and Cystic Fibrosis Service. He was made Professor of Paediatric Respiratory Medicine at King's College London in 1992. He is a past Chairman of the British Paediatric Respiratory Society, the Specialist Advisory Committee in Paediatric Respiratory Medicine at the Royal College of Paediatrics, the UK Cystic Fibrosis Newborn Screening Programme Board and Asthma UK. He is a Trustee of Demelza Hospice Care for Children and Medical Advisor to the Variety Children’s Charity.
He was a member of the CF Trust Research Advisory Committee for five years. He has been a Trustee since 2010 during which time he has been Chairman of the Clinical Advisory Group and is currently Chairman of the Nominations and Development Committee.
David Turner QC
David was called to the Bar in 1992 and has since specialised in commercial insurance, professional liability and commercial product liability cases. He became a Queen's Counsel in 2009. He has three children of whom the youngest was diagnosed with cystic fibrosis in 2008, shortly after her third birthday. His fundraising activities for the Cystic Fibrosis Trust include organising the original Great Strides 65 in the Surrey Hills. David has campaigned publicly to maintain the quality of clinical services and research at his daughter's specialist centre, and was a Patient and Public Engagement member of the Cystic Fibrosis Clinical Reference Group (the body that provided specialist clinical advice to NHS commissioners in England) from when it was formed in 2012 until its disbandment in 2016. He is a lay member of the Trust's Research Strategy Implementation Board and a member of the Finance Committee.
Michael joined the Board in March 2015, bringing his experience of living with cystic fibrosis. A charity blogger and fundraiser, Michael currently works for the Children’s Society as a Philanthropy manager. He and his partner welcomed their first baby in August. Before joining the Board, Michael raised over £6,000 for the Trust by taking on a variety of fundraising challenges, including the London Marathon, skydiving and two appearances in the Nicky’s Whisper Challenge football match.
Hannah joined the board in March 2015. For 15 years she steered the careers of writers, actors and comedians towards Edinburgh Festival victories and BAFTA Awards. This involved developing and selling ideas, putting together creative teams and brokering deals for big-budget films and television series. She is now using her contacts and skills to raise money and awareness for cystic fibrosis. Most recently she worked with her writer husband on the award-winning ‘Breath Before’ film made to show both the realities of living with cystic fibrosis and how the Cystic Fibrosis Trust is aiming to beat it for good. She has two sons, the youngest of whom was diagnosed with CF at five weeks of age.
Joining the Board in March 2015, Louise is a Technical Team Manager at Legal & General, and brings first-hand experience of life with cystic fibrosis, and a determination to make her “time on earth worthwhile.”
Patient wellbeing and clear communication have always been Ffyona’s passion. She originally trained as a nurse in the NHS, bringing her patient insight with her when she joined the respiratory clinical development team at GlaxoSmithKline (GSK). During her time at GSK, Ffyona held a variety of senior roles over a 10 year period.
Ffyona feels strongly that everyone should have access to understandable information about their condition and the medications they are taking. She has instilled this passion for patient education in the medical communications agency she founded in 2007. Ffyona has gained the respect of numerous clients she has worked with across the globe, and also the respect of her team, a large part because of her internal focus and commitment to corporate social responsibility. Over the last few years, the team have fund-raised for a variety of charities including the Cystic Fibrosis Trust.
Ffyona has both friends and family members living with cystic fibrosis and her desire to raise awareness about the condition stems from observing the real life impact the condition has on people close to her.
Ryan joined the board in April 2016, bringing with him 10 years of experience in the pharmaceutical and biotech industry. Currently Ryan works in an EMEA Business Intelligence role for Johnson and Johnson, and previously in international roles with Gilead Sciences and Abbott International. In this time Ryan has amassed deep technical and strategic experience across; immunology, virology, venereology, cystic fibrosis and oncology. Ryan has also worked extensively in the voluntary sector, having also served as the Chairman of a suicide prevention charity in Northern Ireland. Ryan has a personal connection to Cystic Fibrosis through his son Noah.